drugset / Trial / NCT02998996
Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The main purpose of the this study is to evaluate the safety and tolerability of Immunose™ FLU based on Endocine™ and quadrivalent influenza antigen.
Timeline
- Start
- 2016-09
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Influenza antigen | Vaccine | 15 ug | Intranasal |
| Subject | Vacc-4x | Peptide | 1 % | Intranasal |
| Subject | Vacc-4x | Peptide | 2 % | Intranasal |